YTHDF1 and YTHDF2 are associated with better patient survival and an inflamed tumor-immune microenvironment in non-small-cell lung cancer. - Kazuo Tsuchiya; Katsuhiro Yoshimura; Yusuke Inoue; Yuji Iwashita; Hidetaka Yamada; Akikazu Kawase; Takuya Watanabe; Masayuki Tanahashi; Hiroshi Ogawa; Kazuhito Funai; Kazuya Shinmura; Takafumi Suda; et al. (OncoImmunology, 2021)